Xeriant, Inc. (XERI) stock
XERIOTCAircraftFiscal year ends June 30
$0.01+0.00 (+1.51%)
Close on Oct 19, 2026Market cap $15.78MP/E –Yield –
Xeriant r&d expenses
Research and development expenses are spending on new products and technology.
Xeriant's R&D Expenses for the twelve months ending Jun 30, 2026 was $99.91K, up 44.2% year over year. For fiscal 2026 it was $99.91K, up 44.2% from the year before. The highest annual figure on record is $5.27M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $99.91K | +44.2% |
| FY2025 | Jun 30, 2025 | $69.27K | -64.7% |
| FY2024 | Jun 30, 2024 | $196.42K | – |
| FY2023 | Jun 30, 2023 | $0 | -100.0% |
| FY2022 | Jun 30, 2022 | $5.27M | +1311.8% |
| FY2021 | Jun 30, 2021 | $373.11K | +5751.8% |
| FY2020 | Jun 30, 2020 | $6.38K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $0 | -100.0% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $29.64K | -1.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $16.30K | +108586.7% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $53.97K | +103.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $12.47K | -74.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $30.22K | -55.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $15 | -100.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $26.56K | -1.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $49.16K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $67.52K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $52.75K | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $26.98K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $0 | -100.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $0 | -100.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $0 | -100.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0 | -100.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $59.78K | -84.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $7.59K | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $2.86M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $2.34M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $373.11K | +1008310.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $0 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $0 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $0 | -100.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $37 | -98.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $0 | -100.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $0 | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $6.34K | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.90K | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.98K | – |
See a number that looks wrong?